Cargando…
Effectiveness of entecavir in preventing hepatocellular carcinoma development is genotype-dependent in hepatitis B virus-associated liver cirrhosis
BACKGROUND: The oral nucleos(t)ide analogue, entecavir (ETV) was demonstrated to reduce the rate of hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV)-associated liver cirrhosis. However, the reduction of HCC differs in various regions of the world. AIM: To investigate the reduc...
Autores principales: | Tarao, Kazuo, Nozaki, Akito, Chuma, Makoto, Taguri, Masataka, Maeda, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856867/ https://www.ncbi.nlm.nih.gov/pubmed/33584993 http://dx.doi.org/10.4254/wjh.v13.i1.144 |
Ejemplares similares
-
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
por: Tarao, Kazuo, et al.
Publicado: (2019) -
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
por: Tarao, Kazuo, et al.
Publicado: (2020) -
Comparison of unenhanced magnetic resonance imaging and ultrasound in detecting very small hepatocellular carcinoma
por: Tarao, Kazuo, et al.
Publicado: (2021) -
Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis
por: Lee, Hyo-Young, et al.
Publicado: (2019) -
Efficacy and safety of sofosbuvir/velpatasvir with or without ribavirin in hepatitis C genotype 3 compensated cirrhosis: A meta-analysis
por: Loo, Jing Hong, et al.
Publicado: (2022)